Here are the Form 4 insider transactions from Burning Rock Biotech Limited (BNR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BNR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BNR filings page.
Burning Rock Biotech director Han Yusheng reported a series of open-market share purchases. Between June 11 and June 26, 2026, he bought a total of 731,410 ordinary shares (represented by American depositary shares) in seven separate transactions.
Individual trades ranged from 24,760 shares at $8.7394 per ADS to 250,000 shares at $8.0000 per ADS. After the most recent transaction, Han directly owned 18,404,086 ordinary shares. One American depositary share represents ten Class A ordinary shares, and all reported trades are non-derivative open-market purchases.
Burning Rock Biotech Ltd director Han Yusheng bought 314,870 shares in an open-market purchase. The shares were acquired at a weighted average price of $17.36 per share, across multiple trades between $16.10 and $18.99. Following this transaction, he directly owns 17,672,676 shares, reflecting a significant ongoing stake in the company.